EdgeRock Capital’s Colgate-Palmolive CL Stock Holding History

EdgeRock Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-497	Closed	-$35K	–	111
2022 Q3	$35K	Buy	+497	New	+$39K	0.02%	121

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EdgeRock Capital's CL Position: Q4 2022 in Review

EdgeRock Capital sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 497 shares — an estimated $35K sold.

EdgeRock Capital first reported a position in CL in Q3 2022 and held it in 1 quarter. The position peaked at $35K in Q3 2022. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.

EdgeRock Capital reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
EdgeRock Capital sold 497 Colgate-Palmolive shares in Q4 2022, an estimated $35K.
EdgeRock Capital first reported a position in Colgate-Palmolive in Q3 2022 and held it in 1 quarter.
EdgeRock Capital's Colgate-Palmolive position peaked at $35K in Q3 2022.
1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on EdgeRock Capital's 13F filing for Q4 2022, filed 14 Feb 2023.